Use of KC706 for the Treatment of Pemphigus Vulgaris
Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether KC706 is effective in the prevention and
healing of blisters in patients with pemphigus vulgaris, while the patient remains on stable
doses of corticosteroids and/or immunosuppressants.